O163 Autonomic nervous system dysfunction in patients with high obstructive sleep apnea risk

The aim of this study was to compare autonomic nervous system (ANS) function in subjects with high OSA (obstructive sleep apnea) risk versus subjects with low OSA risk. Out of 47 consecutive subjects enrolled (22 females, mean age 48.23±16.09years), 27 had high OSA risk and 20 had low OSA risk accor...

Full description

Saved in:
Bibliographic Details
Published in:Clinical neurophysiology Vol. 128; no. 9; p. e231
Main Authors: Barun, Barbara, Mioc, Marina, Skoric, Magdalena Krbot, Mudrovcic, Monika, Milosevic, Natasa, Crnosija, Luka, Habek, Mario
Format: Journal Article
Language:English
Published: Elsevier B.V 01-09-2017
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The aim of this study was to compare autonomic nervous system (ANS) function in subjects with high OSA (obstructive sleep apnea) risk versus subjects with low OSA risk. Out of 47 consecutive subjects enrolled (22 females, mean age 48.23±16.09years), 27 had high OSA risk and 20 had low OSA risk according to the Berlin Questionnaire (BQ). They all underwent standardized battery of ANS testing, including blood pressure and heart rate response to Valsalva maneuver, deep breathing test and head up tilt table test. Respiratory sinus arrhythmia (RSA), Valsalva ratio (VR) were determined and cardiovagal score of the Composite Autonomic Scoring Scale (CASS) was determined. Adrenergic score was calculated from the blood pressure response during Valslava maneuver and tilt table test. Finally heart rate variability (HRV) was determined in supine and standing positions. High OSA risk subjects had lower RSA compared to low OSA risk subjects (9.96±5.45 vs. 15.17±8.94, p=0.022). Also VR was lower in subject with high OSA risk versus low OSA risk subjects (1.55±0.34 vs. 1.83±0.41, p=0.024). There where no significant differences in CASS adrenergic score and HRV between groups. Pathogenesis of ANS dysfunction in OSA is not elucidated. Sympathetic hyperactivity leads to hypertension but can hardly explain higher cardiac morbidity and mortality. Further research is warranted to investigate the role of vagal down regulation in OSA pathogenesis. High OSA risk is associated with vagal down regulation. These findings confirms presence of vagal down regulation which might reflect central nervous system damage in OSA and also might contribute to cardiac morbidity and mortality.
ISSN:1388-2457
1872-8952
DOI:10.1016/j.clinph.2017.07.173